5-aminosalicylates in inflammatory bowel disease and chronic renal failure: Authors' reply

被引：0
|
作者：
Muller, AF [1 ]
Stevens, PE
McIntyre, AS
Ellison, H
Logan, RF
机构：
[1] Kent & Canterbury Hosp, Dept Gastroenterol, Canterbury, Kent, England
[2] Kent & Canterbury Hosp, Dept Nephrol, Canterbury, Kent, England
[3] Wycombe Gen Hosp, Dept Med, Wycombe, Bucks, England
[4] British Soc Gastroenterol, London, England
[5] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2005年 / 22卷 / 06期
关键词：
D O I：
10.1111/j.1365-2036.2005.02618.x
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：579 / 580
页数：2
相关论文
共 50 条
  • [31] Tolerability of Aminosalicylates in Inflammatory Bowel Disease
    Sauid Ishaq
    Jonathan R.B. Green
    BioDrugs, 2001, 15 : 339 - 349
  • [32] 5-AMINOSALICYLATES USED IN INFLAMMATORY BOWEL-DISEASE (IBD) INHIBIT LPS INDUCED ENDOTHELIAL-CELL PROCOAGULANT ACTIVITY (EPCA)
    HUDSON, M
    NYGARD, G
    MAZURE, G
    DHILLON, AP
    POUNDER, RE
    WAKEFIELD, AJ
    GASTROENTEROLOGY, 1993, 104 (04) : A716 - A716
  • [33] Efficacy of 5-Aminosalicylates for the Maintenance of Remission in Crohn's Disease
    Akobeng, Anthony K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (10): : 1857 - 1857
  • [34] Continuing or stopping 5-aminosalicylates in patients with inflammatory bowel disease on anti-TNF therapy: A nationwide population-based study
    Seo, Jeongkuk
    Kim, Seonok
    Hong, Seung Wook
    Hwang, Sung Wook
    Park, Sang Hyoung
    Yang, Dong-Hoon
    Byeon, Jeong-Sik
    Myung, Seung-Jae
    Yang, Suk-Kyun
    Kim, Ye-Jee
    Ye, Byong Duk
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (03) : 389 - 400
  • [35] Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer-authors' reply
    Bonovas, S.
    Fiorino, G.
    Lytras, T.
    Nikolopoulos, G.
    Peyrin-Biroulet, L.
    Danese, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (12) : 1554 - 1555
  • [36] Letter: rationalising aminosalicylates in inflammatory bowel disease
    Nicolaides, Steven
    Vasudevan, Abhinav
    van Langenberg, Daniel
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 52 (10) : 1619 - 1620
  • [37] Treatment of anaemia in inflammatory bowel disease: authors' reply
    de Silva, A
    Rampton, DS
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (08) : 1274 - 1275
  • [38] AMINOSALICYLATES FOR THE TREATMENT OF INFLAMMATORY BOWEL-DISEASE
    LEICHTNER, AM
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1995, 21 (03): : 245 - 252
  • [39] Effects of 5-aminosalicylates or thiopurines on the progression of low-grade dysplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Zeng, Jian
    Meng, Zhang-Min
    Huang, Xiao-Li
    Gan, Hua-Tian
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (01) : 11 - 18
  • [40] The role of aminosalicylates at the beginning of the new millennium in the treatment of chronic inflammatory bowel disease
    U. Klotz
    European Journal of Clinical Pharmacology, 2000, 56 : 353 - 362
12345